The effect of probiotic therapy on nosocomial infections in the critically ill
Not Applicable
Completed
- Conditions
- Infections and Infestations: Nosocomial infectionsInfections and Infestations
- Registration Number
- ISRCTN51777318
- Lead Sponsor
- Department of Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided at time of registration
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie probiotic efficacy against nosocomial infections in critically ill patients?
How does probiotic therapy compare to standard-of-care in reducing ICU-acquired infections?
Are there specific gut microbiota biomarkers that predict response to probiotic interventions in sepsis-prone ICU patients?
What are the potential adverse events associated with probiotic administration in immunocompromised critical care settings?
How do combination approaches of probiotics with prebiotics or antibiotics impact nosocomial infection rates in intensive care units?